223 results on '"TON, VAN-KHUE"'
Search Results
2. Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group
3. Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group
4. An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device
5. Outcomes of Patients Transferred to Tertiary Care Centers for Treatment of Cardiogenic Shock: A Cardiogenic Shock Working Group Analysis
6. Heart failure related cardiogenic shock: An ISHLT consensus conference content summary
7. Consensus statements from the International Society for Heart and Lung Transplantation consensus conference: Heart failure–related cardiogenic shock
8. Pulmonary Artery Catheter Use and Risk of In-hospital Death in Heart Failure Cardiogenic Shock
9. The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update
10. Treatment Intensity for the Management of Cardiogenic Shock: Comparison Between STEMI and Non-STEMI
11. Abstract 17891: Underutilization of Palliative Care Consults and End-of-Life Care Planning After Cardiogenic Shock
12. Abstract 16479: The Effects of Pulmonary Artery Catheter Usage and Treatment Intensity on Mortality in Patients With Cardiogenic Shock by Etiology
13. Abstract 12328: Impact of Female Sex on Cardiogenic Shock Outcomes - A Cardiogenic Shock Working Group Report
14. Effect of Impella 5.5 on Preexisting Functional Mitral Regurgitation in Patients with Heart Failure–Related Cardiogenic Shock
15. Persistent Iron Deficiency and Dysregulated Hepcidin Levels After Durable Left Ventricular Assist Device Therapy
16. Novel Use of Tamoxifen to Reduce Recurrent Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices
17. Association of Hemometabolic Trajectory and Mortality: Insights From the Cardiogenic Shock Working Group Registry.
18. Short- and long-term adverse events in patients on temporary circulatory support before durable ventricular assist device: An IMACS registry analysis
19. Left ventricular assist device implantation may be feasible in appropriately selected patients with severe renal insufficiency
20. Longitudinal impact of temporary mechanical circulatory support on durable ventricular assist device outcomes: An IMACS registry propensity matched analysis
21. Heart failure related cardiogenic shock: An ISHLT consensus conference content summary
22. Association of Hemo-Metabolic Trajectory and Cardiogenic Shock Mortality: Analysis from the CSWG Registry
23. Post-exercise Oxygen Uptake Recovery Delay In Individuals With Left Ventricular Assist Device
24. Impact of Female Sex on Cardiogenic Shock Outcomes
25. Prognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock
26. TCT-762 Hemodynamic Predictors of In-Hospital Mortality in Cardiogenic Shock: The Trajectory Is What Matters
27. Outcomes of Patients Transferred to Tertiary Care Centers for Treatment of Cardiogenic Shock: A Cardiogenic Shock Working Group Analysis
28. TCT-704 Impact of Sex on Cardiogenic Shock Outcomes: A Cardiogenic Shock Working Group Report
29. Clinical Outcomes of Perioperative Desensitization in Heart Transplant Recipients
30. High Right Ventricular Afterload Is Associated with Impaired Exercise Tolerance in Patients with Left Ventricular Assist Devices
31. Less Invasive Approach to Left Ventricular Assist Device Implantation May Improve Survival in High-Risk Patients
32. Does Chronotropic Incompetence in HFpEF Cause or Result From Exercise Intolerance?
33. Noninvasive Assessment of Right Ventricular Function in Patients with Pulmonary Arterial Hypertension and Left Ventricular Assist Device
34. Elimination of the “Increased Risk” Label Has Not Improved Donor Heart Utilization in the U.S.
35. Effect Of Impella 5.5® On Pre-existing Functional Mitral Regurgitation In Patients With Heart Failure-associated Cardiogenic Shock
36. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis
37. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction
38. Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support
39. Hemodynamic and Clinical Performance of Hearts Donated After Circulatory Death
40. Persistent Iron Deficiency and Dysregulated Hepcidin Levels After Durable Left Ventricular Assist Device Therapy
41. Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions After Left Ventricular Assist Device
42. Reverse Remodeling With Neurohormonal Blockade Following Left Ventricular Assist Device Implantation
43. Absence of Apical Sparing Pattern is Associated with Adverse Outcomes in Transthyretin Cardiac Amyloidosis
44. How to Turn It Down: The Evidence and Opinions Behind Adult Venoarterial Extracorporeal Membrane Oxygenation Weaning
45. Left Ventricular Assist Device Explant and Mitral Valve Replacement for Myocardial Recovery
46. Functional expression of heterologous proteins in yeast: insights into [Ca.sup.2+] signaling and [Ca.sup.2+]-transporting ATPases
47. Using Fluorodeoxyglucose (18F-FDG) PET/CT to monitor treatment response in cardiac sarcoidosis
48. Novel Use of Tamoxifen to Reduce Recurrent Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices
49. Inflow Cannula Position Influences Improvement in Mitral Regurgitation After Ventricular Assist Device Implantation
50. Should we overcome the resistance to bioelectrical impedance in heart failure?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.